Gene · 11091
Papers2,554
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
321 to 340 of 2,554
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| WDR5 facilitates recruitment of N-MYC to conserved WDR5 gene targets in neuroblastoma cell lines. | Oncogenesis | 2023 | 37336886 | PubTator, text mining | PubMed |
| Epigenetic reprogramming of cell cycle genes by ACK1 promotes breast cancer resistance to CDK4/6 inhibitor. | Oncogene | 2023 | 37330596 | PubTator, text mining | PubMed |
| Leveraging a disulfidptosis-based signature to improve the survival and drug sensitivity of bladder cancer patients. | Front Immunol | 2023 | 37325625 | PubTator, text mining | PubMed |
| DPY30 Promotes Proliferation and Cell Cycle Progression of Colorectal Cancer Cells via Mediating H3K4 Trimethylation. | Int J Med Sci | 2023 | 37324189 | PubTator, text mining | PubMed |
| An overview of human single-cell RNA sequencing studies in neurobiological disease. | Neurobiol Dis | 2023 | 37321420 | PubTator, text mining | PubMed |
| Discovery and Structure-Based Design of Inhibitors of the WD Repeat-Containing Protein 5 (WDR5)-MYC Interaction. | J Med Chem | 2023 | 37307526 | PubTator, text mining | PubMed |
| WDR54 exerts oncogenic roles in T-cell acute lymphoblastic leukemia. | Cancer Sci | 2023 | 37302808 | PubTator, text mining | PubMed |
| Natural Products for the Prevention, Treatment and Progression of Breast Cancer. | Cancers (Basel) | 2023 | 37296944 | PubTator, text mining | PubMed |
| CSTF2T facilitates pancreatic adenocarcinoma growth and metastasis by elevating H3K4Me1 methylation of CALB2 via ASH2L. | Cancer Biol Ther | 2023 | 37287122 | PubTator, text mining | PubMed |
| Epigenetic markers and therapeutic targets for metastasis. | Cancer Metastasis Rev | 2023 | 37286865 | PubTator, text mining | PubMed |
| Oncogenic signaling pathways in pancreatic ductal adenocarcinoma. | Adv Cancer Res | 2023 | 37268398 | PubTator, text mining | PubMed |
| Evaluation of Nanopore Sensor Design Using Electrical and Optical Analyses. | ACS Nano | 2023 | 37261404 | PubTator, text mining | PubMed |
| Therapeutic targeting of metabolic vulnerabilities in cancers with MLL3/4-COMPASS epigenetic regulator mutations. | J Clin Invest | 2023 | 37252797 | PubTator, text mining | PubMed |
| Molecular mechanisms and cellular functions of liquid-liquid phase separation during antiviral immune responses. | Front Immunol | 2023 | 37251408 | PubTator, text mining | PubMed |
| Regulation of the Cell Cycle by ncRNAs Affects the Efficiency of CDK4/6 Inhibition. | Int J Mol Sci | 2023 | 37240281 | PubTator, text mining | PubMed |
| H3 histone methylation landscape in male urogenital cancers: from molecular mechanisms to epigenetic biomarkers and therapeutic targets. | Front Cell Dev Biol | 2023 | 37228649 | PubTator, text mining | PubMed |
| Early assessment of circulating exosomal lncRNA-GC1 for monitoring neoadjuvant chemotherapy response in gastric cancer. | Int J Surg | 2023 | 37222716 | PubTator, text mining | PubMed |
| An acetylation-mediated chromatin switch governs H3K4 methylation read-write capability. | Elife | 2023 | 37204295 | PubTator, text mining | PubMed |
| New genetic and epigenetic insights into the chemokine system: the latest discoveries aiding progression toward precision medicine. | Cell Mol Immunol | 2023 | 37198402 | PubTator, text mining | PubMed |
| An overview of extrahepatic cholangiocarcinoma: from here to where? | Front Oncol | 2023 | 37197436 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/11091/papers?page=17